The Expanded Biology of Serotonin

Annual Review of Medicine - Tập 60 Số 1 - Trang 355-366 - 2009
Miles Berger1, J.A. Gray2,3, Bryan L. Roth4
1Department of Psychiatry, University of California, San Francisco, California 94143 USA
2Department of Cellular and Molecular Biology, University of California, San Francisco, California 94143;
3Department of Psychiatry, University of California, San Francisco, California 94143
4Departments of Pharmacology, Medicinal Chemistry, and Psychiatry, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina 27599;

Tóm tắt

Serotonin is perhaps best known as a neurotransmitter that modulates neural activity and a wide range of neuropsychological processes, and drugs that target serotonin receptors are used widely in psychiatry and neurology. However, most serotonin is found outside the central nervous system, and virtually all of the 15 serotonin receptors are expressed outside as well as within the brain. Serotonin regulates numerous biological processes including cardiovascular function, bowel motility, ejaculatory latency, and bladder control. Additionally, new work suggests that serotonin may regulate some processes, including platelet aggregation, by receptor-independent, transglutaminase-dependent covalent linkage to cellular proteins. We review this new “expanded serotonin biology” and discuss how drugs targeting specific serotonin receptors are beginning to help treat a wide range of diseases.

Từ khóa


Tài liệu tham khảo

Rapport MM, 1948, J. Biol. Chem., 176, 1243, 10.1016/S0021-9258(18)57137-4

Roth BL, 2007, The Serotonin Receptors: From Molecular Pharmacology to Human Therapeutics

10.3109/10401239409148985

10.1615/CritRevNeurobiol.v16.i4.10

10.2174/1568026023393796

10.1038/sj.npp.1300027

10.1056/NEJMp068265

10.1053/j.gastro.2006.11.002

Mengod G, 2007, The Serotonin Receptors: From Molecular Pharmacology to Human Therapeutics, 319

10.1016/0306-4522(91)90128-B

10.1126/science.1144400

10.1038/nn1964

10.1007/s00213-003-1683-8

10.1038/nrn1429

10.1002/0470010703.ch9

10.1016/j.ejphar.2004.01.036

10.1038/sj.mp.4002062

10.1602/neurorx.2.4.590

10.1016/j.pharmthera.2005.12.004

10.1111/j.1468-2982.2007.01476.x

10.1111/j.1440-1681.2006.04410.x

10.1172/JCI33374

10.1161/01.CIR.0000079172.43229.CD

10.1001/archpsyc.62.7.792

10.1001/archpsyc.62.7.711

10.1159/000119692

10.1016/S0092-8674(03)01014-6

10.1111/j.1538-7836.2005.01274.x

10.1007/s00392-006-0463-y

10.1023/B:JICE.0000011348.05608.e5

10.1007/s00210-004-0963-0

10.1038/sj.bjp.0706966

10.1517/13543784.12.5.805

10.1161/01.CIR.102.23.2836

10.1124/mol.63.6.1223

10.1161/01.CIR.0000081520.25714.D9

10.1161/01.ATV.20.10.2233

10.1385/CBB:47:1:33

10.1038/nm764

10.1124/mol.104.008268

10.1074/jbc.M604195200

10.1164/rccm.200210-1212OC

10.1124/mi.4.4.3

10.1126/science.1084674

10.1093/jnen/60.3.228

10.1001/jama.296.17.2124

10.1016/S0034-5687(01)00289-4

10.1016/j.resp.2007.06.002

10.1017/S109285290001885X

10.1017/S1462399407000245

10.1210/en.2007-1321

10.1523/JNEUROSCI.4729-07.2008

10.1016/j.ejphar.2004.01.031

10.1016/S0014-2999(03)01285-8

10.1016/S1534-5807(04)00022-X

10.1073/pnas.0708136104

10.1126/science.1123842

10.1016/j.cmet.2007.09.012

10.1007/s00018-006-6112-9

10.1172/JCI200112312

10.1016/S0163-7258(03)00057-3

10.1385/MN:30:2:117

10.1002/cne.21665

10.1592/phco.27.11.1571

10.1213/01.ane.0000255200.42574.22

10.5694/j.1326-5377.2007.tb01282.x

10.1016/j.neubiorev.2006.01.001

10.1016/j.tins.2006.12.002

10.1038/sj.bjp.0706504

10.1080/01443610801912931

10.1016/S0301-2115(00)00367-5

10.1097/01.hjh.0000234115.40648.88

10.1016/j.mehy.2003.10.038

10.1097/JCP.0b013e318166c52e

10.1056/NEJMoa052744

10.1113/jphysiol.2007.129726

Oropeza MV, 2000, Life Sci., 66, PL345

10.1002/jcp.1041460310

10.1038/sj.mp.4001949

10.1001/archinte.144.6.1143

10.1056/NEJM199708283370901

Fitzgerald LW, 2000, Mol. Pharmacol., 57, 75

10.1038/nrd1900

10.1016/j.amjcard.2007.06.045

10.1056/NEJMoa062222

10.1056/NEJMoa054830